These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 12951873)

  • 1. [Ocular subclinical changes in significant carotid stenosis].
    Hejcmanová D; Svĕrák J; Hobza V; Kvasnicka J; Langrová H
    Cesk Slov Oftalmol; 2003 Jul; 59(4):221-7. PubMed ID: 12951873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of carotid endarterectomy in patients with stenosis of carotid arteries and acute vision impairment].
    Gavrilenko AV; Kuklin AV; Kiseleva TN
    Angiol Sosud Khir; 2013; 19(1):106-12. PubMed ID: 23531668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma.
    Parisi V; Miglior S; Manni G; Centofanti M; Bucci MG
    Ophthalmology; 2006 Feb; 113(2):216-28. PubMed ID: 16406535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choroideremia: variability of clinical and electrophysiological characteristics and first report of a negative electroretinogram.
    Renner AB; Kellner U; Cropp E; Preising MN; MacDonald IM; van den Hurk JA; Cremers FP; Foerster MH
    Ophthalmology; 2006 Nov; 113(11):2066.e1-10. PubMed ID: 16935340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of retinitis pigmentosa patients with multifocal electroretinography.
    Nagy D; Schönfisch B; Zrenner E; Jägle H
    Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4664-71. PubMed ID: 18566474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inapparent visual field defects in multiple sclerosis patients.
    Vidović T; Cerovski B; Vidović DH; Cerovski J; Novak-Laus K
    Coll Antropol; 2005; 29 Suppl 1():67-73. PubMed ID: 16193681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing multifocal VEP and standard automated perimetry in high-risk ocular hypertension and early glaucoma.
    Fortune B; Demirel S; Zhang X; Hood DC; Patterson E; Jamil A; Mansberger SL; Cioffi GA; Johnson CA
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1173-80. PubMed ID: 17325161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic segmentation of MR perfusion images in patients with unilateral carotid stenosis using independent component analysis.
    Kao YH; Teng MM; Liu KC; Lam IP; Lin YC
    J Magn Reson Imaging; 2008 Nov; 28(5):1125-32. PubMed ID: 18972353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of retinal abnormalities on the multifocal visual evoked potential.
    Chen JY; Hood DC; Odel JG; Behrens MM
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4378-85. PubMed ID: 17003429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparative analysis of standard automated perimetry and short wavelength automated perimetry in early diagnosis of glaucoma].
    Chiseliţă D; Crenguţa MI; Danielescu C; Mihaela NM
    Oftalmologia; 2006; 50(2):94-102. PubMed ID: 16927766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Full-field ERG, multifocal ERG and multifocal VEP in patients with retinitis pigmentosa and residual central visual fields.
    Gränse L; Ponjavic V; Andréasson S
    Acta Ophthalmol Scand; 2004 Dec; 82(6):701-6. PubMed ID: 15606467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Light-induced amaurosis fugax].
    Calleja S; Vega F; Zeidán N; Lahoz CH
    Neurologia; 2006 Apr; 21(3):159-61. PubMed ID: 16575631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiodarone and optic neuropathy.
    Domingues MF; Barros H; Falcão-Reis FM
    Acta Ophthalmol Scand; 2004 Jun; 82(3 Pt 1):277-82. PubMed ID: 15115448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contralateral high-grade carotid artery stenosis or occlusion is not associated with increased risk for poor neurologic outcome after elective carotid stent placement.
    Sabeti S; Schillinger M; Mlekusch W; Nachtmann T; Lang W; Ahmadi R; Minar E
    Radiology; 2004 Jan; 230(1):70-6. PubMed ID: 14695388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern ERG as an early glaucoma indicator in ocular hypertension: a long-term, prospective study.
    Bach M; Unsoeld AS; Philippin H; Staubach F; Maier P; Walter HS; Bomer TG; Funk J
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4881-7. PubMed ID: 17065502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between photopic negative response and retinal nerve fiber layer thickness and optic disc topography in glaucomatous eyes.
    Machida S; Gotoh Y; Toba Y; Ohtaki A; Kaneko M; Kurosaka D
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):2201-7. PubMed ID: 18436853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of latest-generation self-expanding stents in patients with NASCET-ineligible severe symptomatic extracranial internal carotid artery stenosis.
    Linfante I; Hirsch JA; Selim M; Schlaug G; Caplan LR; Reddy AS
    Arch Neurol; 2004 Jan; 61(1):39-43. PubMed ID: 14732618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of saccadic vector optokinetic perimetry: a method of automated static perimetry for children using eye tracking.
    Murray IC; Fleck BW; Brash HM; Macrae ME; Tan LL; Minns RA
    Ophthalmology; 2009 Oct; 116(10):2017-26. PubMed ID: 19560207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between carotid intima-media thickness, atherosclerosis risk factors and angiography findings in patients with coronary artery disease].
    Kabłak-Ziembicka A; Przewłocki T; Kostkiewicz M; Pieniazek P; Mura A; Podolec P; Tracz W
    Przegl Lek; 2003; 60(10):612-6. PubMed ID: 15052717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ocular symptoms as an indication for carotid endarterectomy].
    Pribán V; Fiedler J; Chlouba V
    Cesk Slov Oftalmol; 2006 Sep; 62(5):354-9. PubMed ID: 17039923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.